There are four major subtypes of breast cancer: luminal A (40–60%), luminal B (10–20%), HER2 (10–15%) and triple negative breast cancer (TNBC) (15–20%), which lack the three receptors that define the other subtypes [3]. Here, ERBB2 is linked to breast carcinoma.